Publication | Closed Access

An Open-Label Pilot Study of a Formulation Containing the Anti-Inflammatory Flavonoid Luteolin and Its Effects on Behavior in Children With Autism Spectrum Disorders

Open-label Pilot StudyPsychiatryAutism Spectrum DisordersMedicineAnti-inflammatory Flavonoid LuteolinActive IngredientAutismBehavioral IssuePharmacotherapyDevelopmental DisorderPharmacologyDrug Discovery